class=”imagewrap has-source-dimensions”
data-crop-type=”wide”
style=”
–source-width: 2280;
–source-height: 1283;
”
>

A vial of the experimental Novavax coronavirus vaccine is ready for use in a London study in 2020. Novavax’s vaccine candidate contains a noninfectious bit of the virus — the spike protein — with a substance called an adjuvant added that helps the body generate a strong immune response.
Alastair Grant/AP
hide caption
toggle caption
Alastair Grant/AP

